S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
Clinical trial NCT02438722 · COMPLETED
Trial details
- NCT number
- NCT02438722
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-07
- Primary completion
- 2018-09-25
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.